Abstract
Aim Neonatal hemolysis increases bilirubin production rates, which can then lead to severe hyperbilirubinemia and bilirubin neurotoxicity. During hemolysis, heme is degraded by heme oxygenase (HO), which can be induced under stress conditions. It is known that neonatal sepsis is a risk factor for hemolysis and severe hyperbilirubinemia. Here, we evaluated if an exposure to lipopolysaccharide (LPS) to induce sepsis can upregulate HO‐1, further increasing in vivo bilirubin production rates in mouse pups under heme loads. Methods 3‐day‐old pups were given LPS (1250 μg/kg) or saline (controls). Liver HO enzyme activity, HO‐1 mRNA, and HO‐1 protein were measured post‐LPS exposure. We then assessed the effects of LPS treatment on in vivo bilirubin production rates after heme loading. Results Liver HO activity significantly increased (142%) over controls 24 hours after treatment with LPS (1250 μg/kg) without mortality. Liver HO‐1 mRNA was significantly upregulated 2.47‐fold at 24 hours post‐LPS administration, while liver HO‐1 protein increased 1.29‐fold 24 hours post‐LPS treatment. After heme loading, pups exposed to LPS had significantly higher bilirubin production rates (1.30‐fold) compared with age‐matched, saline‐treated controls. Conclusion Low‐dose LPS treatment can upregulate liver HO‐1 expression and may underlie the severe hyperbilirubinemia seen in septic infants, particularly when undergoing hemolysis.

This publication has 20 references indexed in Scilit: